Chief Medical Officer

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases

Spyre Therapeutics announces first patient dosed in Phase 3 SKYWAY trial

Spyre Therapeutics to Participate in Stifel 2025 Virtual Immunology and Inflammation Forum

Spyre Therapeutics reports Q2 EPS (49c), consensus (71c)

Clinical Trial Manager

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for inflammatory bowel disease and other immune-mediated diseases. The Clinical Trial Manager will oversee the management of clinical trials, ensuring compliance with regulatory requirements while collaborating with internal teams and external partners to drive successful trial execution.

Clinical Trial Manager, Clinical Operations

SVP, People

Director Program Management

Senior Clinical Trial Manager

Sign up with Google

Sign in with Google